Search Results - "Kverneland, Anders H"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Age and gender leucocytes variances and references values generated using the standardized ONE‐Study protocol by Kverneland, Anders H., Streitz, Mathias, Geissler, Edward, Hutchinson, James, Vogt, Katrin, Boës, David, Niemann, Nadja, Pedersen, Anders Elm, Schlickeiser, Stephan, Sawitzki, Birgit

    Published in Cytometry. Part A (01-06-2016)
    “…Flow cytometry is now accepted as an ideal technology to reveal changes in immune cell composition and function. However, it is also an error‐prone and…”
    Get full text
    Journal Article
  2. 2

    Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumab by Kverneland, Anders H., Enevold, Christian, Donia, Marco, Bastholt, Lars, Svane, Inge Marie, Nielsen, Claus H.

    Published in Oncoimmunology (04-05-2018)
    “…Introduction: Checkpoint inhibitors, including the CTLA-4 blocking antibody ipilimumab, have become the new standard therapy for many metastatic cancers…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Differential ultracentrifugation enables deep plasma proteomics through enrichment of extracellular vesicles by Kverneland, Anders H., Østergaard, Ole, Emdal, Kristina Bennet, Svane, Inge Marie, Olsen, Jesper Velgaard

    Published in Proteomics (Weinheim) (01-04-2023)
    “…Human plasma is a rich source of biomedical information and biomarkers. However, the enormous dynamic range of plasma proteins limits its accessibility to mass…”
    Get full text
    Journal Article
  5. 5

    Fully Automated Workflow for Integrated Sample Digestion and Evotip Loading Enabling High-Throughput Clinical Proteomics by Kverneland, Anders H., Harking, Florian, Vej-Nielsen, Joel Mario, Huusfeldt, Magnus, Bekker-Jensen, Dorte B., Svane, Inge Marie, Bache, Nicolai, Olsen, Jesper V.

    Published in Molecular & cellular proteomics (01-07-2024)
    “…Protein identification and quantification is an important tool for biomarker discovery. With the increased sensitivity and speed of modern mass spectrometers,…”
    Get full text
    Journal Article
  6. 6

    Proteomics to study cancer immunity and improve treatment by Franciosa, Giulia, Kverneland, Anders H., Jensen, Agnete W. P., Donia, Marco, Olsen, Jesper V.

    Published in Seminars in immunopathology (01-03-2023)
    “…Cancer survival and progression depend on the ability of tumor cells to avoid immune recognition. Advances in the understanding of cancer immunity and tumor…”
    Get full text
    Journal Article
  7. 7

    Bone marrow toxicity and immune reconstitution in melanoma and non-melanoma solid cancer patients after non-myeloablative conditioning with chemotherapy and checkpoint inhibition by Kverneland, Anders H., Borch, Troels Holz, Granhøj, Joachim, Sengeløv, Henrik, Donia, Marco, Svane, Inge Marie

    Published in Cytotherapy (Oxford, England) (01-08-2021)
    “…Lymphodepletion with non-myeloablative (NMA) chemotherapy is currently a prerequisite for adoptive cell therapy (ACT). ACT based on tumor-infiltrating…”
    Get full text
    Journal Article
  8. 8

    Abstract 1: Biomarkers of response and acquired resistance to TIL-ACT in solid tumors by Robinson, Welles, Castro, Andrea, Al-Bakir, Maise, Gartner, Jared J., Chamberlain, Christopher Aled, Kverneland, Anders H., Borch, Troels H., Svane, Inge Marie, Donia, Marco, Robbins, Paul, Litchfield, Kevin

    Published in Cancer research (Chicago, Ill.) (22-03-2024)
    “…Background: Cancer immunotherapy has revolutionized cancer treatment in the last decade. However, most patients either do not respond to immunotherapy or…”
    Get full text
    Journal Article